![Michael Hufford](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Hufford
Directeur Général chez LyGenesis, Inc.
Postes actifs de Michael Hufford
Sociétés | Poste | Début | Fin |
---|---|---|---|
LyGenesis, Inc.
![]() LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Directeur Général | 01/05/2018 | - |
Fondateur | - | - | |
Morphoceuticals, Inc.
![]() Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | 18/04/2024 |
Historique de carrière de Michael Hufford
Anciens postes connus de Michael Hufford
Sociétés | Poste | Début | Fin |
---|---|---|---|
e-Nicotine Technology, Inc.
![]() e-Nicotine Technology, Inc. BiotechnologyHealth Technology e-Nicotine Technology, Inc. develops next generation of state-of-the-art electronic nicotine delivery products. It engages in developing electronic nicotine delivery devices that produce a condensation aerosol of nicotine using its thermal drug delivery technology. The firm’s devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was founded by Jeffrey S. Williams, Michael Hufford and Martin Wensley in 2012 and is headquartered in Draper, UT. | Directeur/Membre du Conseil | 01/01/2012 | - |
Directeur Technique/Scientifique/R&D | 01/01/2012 | - | |
Fondateur | 01/01/2012 | - |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 2 |
Founder | 2 |
Chief Executive Officer | 2 |
Sectorielle
Health Technology | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
e-Nicotine Technology, Inc.
![]() e-Nicotine Technology, Inc. BiotechnologyHealth Technology e-Nicotine Technology, Inc. develops next generation of state-of-the-art electronic nicotine delivery products. It engages in developing electronic nicotine delivery devices that produce a condensation aerosol of nicotine using its thermal drug delivery technology. The firm’s devices deliver the right dose of nicotine using the right sized aerosol particles for deep lung delivery to help individuals transition from smoking. The company was founded by Jeffrey S. Williams, Michael Hufford and Martin Wensley in 2012 and is headquartered in Draper, UT. | Health Technology |
LyGenesis, Inc.
![]() LyGenesis, Inc. BiotechnologyHealth Technology LyGenesis, Inc. operates as a biotechnology company. It develops an organ regeneration technology platform enabling a patient's lymph nodes to be used as bioreactors to regrow functioning ectopic organs. The company is headquartered in Pittsburgh, PA. | Health Technology |
Morphoceuticals, Inc.
![]() Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Morphoceuticals, Inc. is an American US-based biotech company that pioneers bioelectric approaches to access anatomical programming, which is a core component of our biological operating system. The company uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies. | Commercial Services |
- Bourse
- Insiders
- Michael Hufford
- Expérience